CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019
Revenue:
Total net revenue	$ 78,946	$ 64,107	$ 157,624	$ 119,290
Operating expenses:
Research and development	559	0	559	0
General and administrative	2,596	4,347	5,159	7,362
Total operating expenses	3,155	4,347	5,718	7,362
Income from operations	75,791	59,760	151,906	111,928
Other income (expense), net	30	(8)	98	(7)
Interest income	158	1,403	1,460	2,378
Interest expense	(4,561)	(4,661)	(9,077)	(9,278)
Changes in fair values of equity investments	46,698	0	68,613	0
Income before income taxes	118,116	56,494	213,000	105,021
Income tax expense, net	19,891	10,433	35,823	18,941
Net income	98,225	46,061	177,177	86,080
Net income attributable to noncontrolling interest	21,381	8,321	34,896	14,550
Net income attributable to Innoviva stockholders	$ 76,844	$ 37,740	$ 142,281	$ 71,530
Basic net income per share attributable to Innoviva stockholders	$ 0.76	$ 0.37	$ 1.40	$ 0.71
Diluted net income per share attributable to Innoviva stockholders	$ 0.69	$ 0.34	$ 1.27	$ 0.65
Shares used to compute Innoviva basic and diluted net income per share:
Shares used to compute basic net income per share	101,324	101,151	101,280	101,105
Shares used to compute diluted net income per share	113,545	113,391	113,527	113,384
Royalty revenue from a related party
Revenue:
Total net revenue	$ 68,946	$ 64,107	$ 147,624	$ 119,290
Revenue from collaborative arrangements with a related party
Revenue:
Total net revenue	$ 10,000	$ 0	$ 10,000	$ 0